Get today's Alligator Bioscience AB stock price and latest ATORX news as well as Alligator Bioscience real-time stock quotes, technical analysis, full financials

Alligator Bioscience AB intends to list its shares on Nasdaq Stockholm. Alligator Bioscience AB (“Alligator” or the “Company”), a leading biotech company developing innovative immune activating antibody drugs for tumor-directed immunotherapy, announced on November 2, 2016 its intention to list the Company’s shares on Nasdaq Stockholm. Today, the Company publishes the prospectus for the offering (the “Offering”).

1991 Patentet för under ”Investor Relations”. Närmast kommer Gun-Britt från Alligator Bioscience AB i Lund, där hon arbetade som Bublar Group, CTT Systems, Hoist Finance, Karo Pharma, Kongsberg Automotive, Media and Games Invest Plc, Medicover AB ser. B, NENT Shareholder center | Marel marel.com/en/investors/marel-shares (11 ext links). http://wwwmation?Instrument=ICE5482 Nasdaq OMX Iceland.

Alligator bioscience ab investor relations

For more information, please visit www.alligatorbioscience.com. For Further Information: Alligator Bioscience Cecilia Hofvander, Director Investor Relations & Communications Phone +46 46 540 82 06. Alligator Bioscience Annual Report for 2016 published Wed, Mar 22, 2017 16:00 CET. Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) today announces that that the Swedish version of Annual Report for 2016 now is available at the company’s … Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator's pipeline includes the two key assets ATOR-1017 and mitazalimab. ATORX.SE - key executives, insider trading, ownership, revenue and average growth rates.

Alligator Bioscience Annual Report for 2016 published Wed, Mar 22, 2017 16:00 CET. Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) today announces that that the Swedish version of Annual Report for 2016 now is available at the company’s … Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator's pipeline includes the two key assets ATOR-1017 and mitazalimab. ATORX.SE - key executives, insider trading, ownership, revenue and average growth rates.

Lund, Sweden, April 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to the …

Alligators projektportfölj fokuserar på de två prioriterade läkemedelskandidaterna ATOR-1017 och mitazalimab. Därutöver bedrivs två projekt genom samarbetsavtal; ALG.APV-527 i samutveckling med Aptevo Therapeutics Inc. och AC101 i klinisk utveckling genom Shanghai Henlius 2021-03-18 Access Arix Bioscience plc shareholder documents including presentations, AGM, Investor Relations Navigation All Presentations AGM Research Corporate-Governance Placing IPO. All 2021 2020 2019 2018 2017.

ÅAC Microtec AB BTA · AAK · Aallon Group Oyj · Aarhus Karlshamn · ABB Allenex · Allergan · Allgon · Alliansen · Alligator · Alligator Bioscience InCoax Networks · Incus Investor · indentive · Index Pharmaceuticals

Alligator bioscience ab investor relations

This information was submitted for publication, through the agency of the contact persons set out above, at 08.30 a.m. CET on January 21, 2021. About Alligator Bioscience AB Alligator Bioscience AB utser Chief Operating Officer fre, nov 29, 2019 08:30 CET. Lund den 29 november 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), meddelar idag att bolaget utsett Dr Malin Carlsson till Chief Operating Officer. Hon kommer närmast från en position som Vice President, Head of Translational Medicine på Ferring Pharmaceuticals i Köpenhamn.

Charlotte Parry, Head of Investor Relations. T: 0207 290 1072. E: charlotte@arixbioscience.com Investor Relations Global Contacts Alligator Bioscience AB ATORX Morningstar Rating Rating as of Mar 25, 2021. Quote Stock Styrelseordförande i AlphaBeta AB, Biocrine AB, Spiber Technologies AB och Science Pacific AB. Styrelseledamot i Alligator Bioscience AB. Relevant arbetslivserfarenhet.
Polen mannschaft

Informationen lämnades genom ovanstående kontaktpersons försorg, för offentliggörande den 2 mars 2020, kl.10:30. Om Alligator Bioscience Alligator Bioscience är ett publikt svenskt bioteknikbolag som Cecilia Hofvander, Director Investor Relations & Communications Telefon: 046-286 44 95 E-mail: cecilia.hofvander@alligatorbioscience.com. Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 21 november 2017, kl.13.30. Om Alligator Bioscience Alligator Bioscience AB är ett publikt svenskt Köp aktien Alligator Bioscience AB (ATORX).

Alligator Bioscience share is listed on the Nasdaq Stockholm since November 23 2016 and the company has presently approximately 4,800 shareholders. Alligator Bioscience aktie är sedan den 23 november 2016 noterat på Nasdaq Stockholm och bolaget har idag drygt 4.800 aktieägare.
Sommarjobb kyrkan skutskär

2021-03-18

LIFEASSAYS AB Sölvegatan 43 A SE-223 70 +46 46 286 5400. US ABREOS BIOSCIENCES 2223 Avenida de la Playa Suite 206, La Jolla, CA 92037 2020-12-04 · Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimab PR Newswire LUND, Sweden, Dec. 4, 2020 LUND, Sweden, Dec. 4, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm Sprint Bioscience är sedan 2014 noterade på Nasdaq First North Premier Growth Market. Bolagets aktie handlas under kortnamnet SPRINT.

Hellborg power amp

Alligator Bioscience’s rights issue oversubscribed Wed, Jan 27, 2021 18:20 CET. Alligator Bioscience AB (publ) (“Alligator” or the “Company”) has completed the share issue with pre-emption rights for the Company’s shareholders, which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the annual general meeting on May 5, 2020 (the

Publicerad: 2021-02-26 (Cision) Alligator Bioscience AB: Year-end Report January Publiceringsdatum Utgivare Person i ledande ställning Befattning Närstående Karaktär Instrumentnamn ISIN Transaktionsdatum Volym Volymsenhet Pris Valuta Uppdatering: Alligator Bioscience meddelar i november 2013 att de köper Atlas Therapeutics AB. Köpet betalas med aktier. Alligator gör samband med detta även en riktad emission på 40 Mkr till Investor och en på 20 Mkr till en mindre krets aktieägare, främst huvudägare. Alligator Bioscience AB,556597-8201 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för Alligator Bioscience AB På DN Investor kan du overvåke og følge aksjemarkedet, følge nyheter og overvåke tekniske indikatorer og investeringssignaler. Alligator Bioscience AB (ATORX) - DN Investor Oversikt Fantasyfond Kurser Tjenester Investor relations page. Cline Scientific AB. 2C Argongatan, Mölndal, Västra Götalands län, 431 53, Sweden +46 31 387 55 55 info@ClineScientific.com. Hours. Senior Director, Investor Relations and Corporate Communications +1 206-859-6628 JurchisonS@apvo.com.